Citation Impact
Citing Papers
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
2015
Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis
2021
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study
2002
Acute kidney injury
2012 Standout
Liver fibrosis
2005 Standout
Hepatocellular carcinoma
2018 Standout
Human serum albumin: From bench to bedside
2011
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Management of adult patients with ascites due to cirrhosis†
2004
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
2010
Descending control of pain
2002 Standout
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling
2002
Burden of liver diseases in the world
2018 Standout
Liver cirrhosis
2014
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
2002
Incidence and Mortality of Acute‐on‐Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis
2019
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
2012
Albumin–drug interaction and its clinical implication
2013 Standout
Acute-on chronic liver failure
2012
Renal Failure in Cirrhosis
2009
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Seasonal changes in plasma glucocorticoid concentrations in free-living vertebrates
2002 Standout
Hepatocellular carcinoma
2021 Standout
Acute Kidney Injury: New Concepts
2008
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Expanding consensus in portal hypertension
2015 Standout
Vascular disorders of the liver # †
2008 Standout
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta‐analysis of randomized controlled trials
2010
Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD
2003
Acute kidney injury
2019 Standout
Management of Cirrhosis and Ascites
2004
Acute kidney injury
2021 Standout
Daily and Seasonal Variation in Response to Stress in Captive Starlings (Sturnus vulgaris): Corticosterone
2000
Hepatorenal Disorders
2015
Management of adult patients with ascites caused by cirrhosis†
1998
Global burden of liver disease: 2023 update
2023 Standout
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome
2018
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Advances in alcoholic liver disease
2003
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Albumin Therapy in Clinical Practice
2005
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Clinical states of cirrhosis and competing risks
2017
Hepatocellular carcinoma
2022 Standout
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts.
1993
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocellular Carcinoma
2019 Standout
The Evolving Challenge of Infections in Cirrhosis
2021
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
2007
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
Alcoholic Hepatitis
2009
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Portal Hypertension and Its Complications
2008
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
2017
Acute kidney injury in cirrhosis: implications for liver transplantation
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of A. Sticca being referenced
Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial
2008
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features
2006
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
1999
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis
2017
Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms
2012
Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites
1998
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial
2009
Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites
2000
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis
2020
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections
2017
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?
2015
Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study
2015
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial
2015
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real‐life cross‐sectional study
2014
Incidence, predictors and outcomes of acute on chronic liver failure in outpatients with cirrhosis
2016